Overview
Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes
Status:
Completed
Completed
Trial end date:
2002-11-20
2002-11-20
Target enrollment:
0
0
Participant gender:
All
All
Summary
This trial is conducted in Europe. The aim of this trial is to compare the pharmacokinetic profile of two different methods of insulin administration in children with type 1 diabetes.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Novo Nordisk A/STreatments:
Insulin
Insulin, Globin Zinc
Criteria
Inclusion Criteria:- Type 1 diabetes
- Treatment for at least 12 months
- HbA1c lesser or equal to 11.0%
- Body weight between 25 and 80 Kg
- Capable to use the device
Exclusion Criteria:
- Any diseases other than diabetes requiring prescriptive medication
- Known or suspected allergy to trial product or related products
- Active proliferative retinopathy as judged by the Investigator
- Recurrent severe hypoglycaemia as judged by the Investigator
- The receipt of any investigational drug within 4 weeks prior to this trial